# Patient Care Plan

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Emile Griffith (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-BX005-SYN-TD
- Date: 2005-05-05
- Fictional facility: St. Posthumous Health Center
- Fictional author: Celeste Fairbanks-Ochieng, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

## What we are working on

- He wants to know why he forgets things and wants to keep living at home **S**
- He still dreams about the fight in which his opponent died and wants the nightmares to ease **S**
- His care partner worries about him getting lost and about managing as things change **S**

## Your goals

- Find the cause of the memory problems and explain it to him in a way he can take in. Target: 2005-06-16. Recorded outcome: Mild cognitive impairment most likely due to traumatic brain injury; explained with his care partner present, at his request, with a written summary. **S**
- A clinically meaningful fall in PTSD symptoms (PCL-5 down at least 10 points) by four months. Target: 2005-09-15. Recorded outcome: PCL-5 from 41 to 26 after cognitive processing therapy and sertraline. **S**
- Nightmares no more than about once a week, with at least six hours of sleep most nights. Target: 2005-10-27. Recorded outcome: Nightmares about once every two weeks; sleeping about six and a half hours. **S**
- No falls, with a balance and strength program. Target: 2005-10-27. Recorded outcome: No falls; Timed Up and Go from 13 to 10 seconds after physical therapy and a home program. **S**
- Name a health care agent and record his goals of care while he can take part fully. Target: 2005-08-04. Recorded outcome: Health care agent named and goals of care recorded at the annual wellness visit. **S**

## What we agreed to do

- Cognitive work-up under the Alzheimer's Association guideline: history from him and his care partner, MoCA, function, depression and PTSD screening, first-tier blood tests (blood count, metabolic panel, B12, TSH), a medicine review for anticholinergic and sedating drugs, a sleep apnea screen, hearing and vision checks, and brain MRI. Guideline: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care (2024); Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for primary care (2024); CMID: Clinical Monitoring Intelligence Database, Non-Alzheimer's dementia and Depression/Bipolar/Mood Disorders monographs (2026) **S**
- Cognitive neurology consultation at the memory clinic to stage the impairment, weigh traumatic brain injury, traumatic encephalopathy syndrome, Alzheimer's disease, vascular disease and the effects of PTSD and depression, and choose further testing. Guideline: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care (2024); National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome (2021) **S**
- PTSD treatment by shared decision: cognitive processing therapy with the clinic psychologist, weekly for about twelve sessions, adapted for memory problems; and sertraline 25 mg each morning, raised to 50 mg after four to six weeks if tolerated, with sodium checked two weeks after starting and after the increase; benzodiazepines avoided. Guideline: VA/DoD Clinical Practice Guideline for Management of Posttraumatic Stress Disorder and Acute Stress Disorder (2023); American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults (2023) **S**
- Collaborative safety plan with warning signs, coping steps, people to call, the clinic number and the 988 Suicide & Crisis Lifeline; medicines kept by his care partner; PHQ-9 item 9 and safety reviewed at every visit. Guideline: VA/DoD Clinical Practice Guideline for Management of Posttraumatic Stress Disorder and Acute Stress Disorder (2023); VA/DoD Clinical Practice Guideline for Assessment and Management of Patients at Risk for Suicide (2024) **S**
- Falls: STEADI assessment, physical therapy for balance and strength with a home program, and a home safety check. Guideline: CMID: Clinical Monitoring Intelligence Database, Non-Alzheimer's dementia and Depression/Bipolar/Mood Disorders monographs (2026); STEADI (Stopping Elderly Accidents, Deaths and Injuries): Clinical Resources (2024) **S**
- Measurement-based care: PCL-5 and PHQ-9 at each chronic-care visit during treatment; MoCA yearly or sooner with change; medicine review every visit. Guideline: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care (2024); VA/DoD Clinical Practice Guideline for Management of Posttraumatic Stress Disorder and Acute Stress Disorder (2023); CMID: Clinical Monitoring Intelligence Database, Non-Alzheimer's dementia and Depression/Bipolar/Mood Disorders monographs (2026) **S**
- After the diagnosis: no cholinesterase inhibitor or memantine, which are not shown to help mild cognitive impairment or traumatic brain injury; memory strategies (one calendar, phone reminders, a fixed daily routine), exercise, social activity, sleep and blood pressure care; repeat neuropsychological testing in twelve to eighteen months or sooner with change; Alzheimer's disease biomarker testing explained and declined for now, as it would not change his care. Guideline: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care (2024); National Institute of Neurological Disorders and Stroke Consensus Diagnostic Criteria for Traumatic Encephalopathy Syndrome (2021); CMID: Clinical Monitoring Intelligence Database, Non-Alzheimer's dementia and Depression/Bipolar/Mood Disorders monographs (2026) **S**
- Travel and money safety: carry a card with his address and his care partner's number, share his phone location, travel with company on unfamiliar routes, and set up shared oversight of bills. Guideline: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care (2024) **S**
- Caregiver support: education about mild cognitive impairment and PTSD, the Alzheimer's Association 24/7 Helpline (which serves all causes of cognitive impairment), a caregiver class and a burden check; the Medicare GUIDE model explained for if dementia develops later. Guideline: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care (2024); Guiding an Improved Dementia Experience (GUIDE) Model (2024) **S**
- Advance care planning while he can take part fully: a health care agent, his values and goals of care, at the annual wellness visit. Guideline: Alzheimer's Association clinical practice guideline for the Diagnostic Evaluation, Testing, Counseling, and Disclosure of Suspected Alzheimer's Disease and Related Disorders (DETeCD-ADRD): Executive summary of recommendations for specialty care (2024); CMID: Clinical Monitoring Intelligence Database, Non-Alzheimer's dementia and Depression/Bipolar/Mood Disorders monographs (2026) **S**

## Follow-up

- 2005-05-05: Establishing care with his care partner for memory loss and confusion: cognitive testing, reversible causes, PTSD and depression screening with a safety assessment, falls, and the plan **S**
- 2005-05-19: Two-week review, seen the same day by cognitive neurology: brain MRI, staging, traumatic encephalopathy syndrome and other causes, sertraline and sodium **S**
- 2005-06-16: Six-week review: neuropsychological testing, the diagnosis and the plan, PTSD treatment, safety and caregiver support **S**
- 2005-08-04: Subsequent annual wellness visit **S**
- 2005-09-15: Four-month review: PTSD after cognitive processing therapy, mood, sodium, falls and caregiver strain **S**
- 2005-10-27: Six-month review: PTSD, mood, cognition, safety and the plan for the year ahead **S**

This teaching document does not replace care from a qualified clinician.
